Table 2 Base-case results costs and effects
Diagnostic strategies | Increments | |||||
|---|---|---|---|---|---|---|
|  | cTnT | hsTnT | hsTnT + H-FABP | hsTnT vs cTnT | hsTnT + H-FABP vs cTnT | hsTnT + H-FABP vs hsTnT |
Discounted cost | € 15115.62 | € 15137.2 | € 15187.74 | € 30.70 | € 86.61 | € 55.91 |
Discounted LYGs | 2.286 | 2.292 | 2.296 | 0.006 | 0.010 | 0.0037 |
Discounted QALYs | 1.657 | 1.662 | 1.664 | 0.004 | 0.007 | 0.0025 |
ICER | ||||||
| Â | Incremental cost per LYG | Incremental cost per QALY | ||||
cTnT | Reference strategy | Reference strategy | ||||
hsTnT vs cTnT | € 4945 | € 7370 | ||||
hsTnT + H-FABP vs cTnT | € 8780 | € 13084 | ||||
hsTnT + H-FABP vs hsTnT | € 15286 | € 22781 | ||||